Skip to content

Drug interactions

Brigatinib + Rimegepant

Severity: Moderate

Brigatinib and Rimegepant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Brigatinib is a weak to moderate CYP3A4 inducer and may lower rimegepant exposure. Reduced efficacy for acute migraine is possible.

What this interaction means in plain words

Brigatinib and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Brigatinib belongs to Oncology; Rimegepant belongs to Central Nervous System.

Evidence level: Low

Why it happens

Induction of CYP3A4 increases rimegepant clearance.

What to do

Avoid concurrent use where possible and select another acute migraine treatment. If used, monitor for reduced response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brigatinib and Rimegepant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brigatinib with Rimegepant?

MediHelp rates the interaction as moderate. Brigatinib and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Brigatinib is a weak to moderate CYP3A4 inducer and may lower rimegepant exposure. Reduced efficacy for acute migraine is possible.

How serious is the interaction between Brigatinib and Rimegepant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and select another acute migraine treatment. If used, monitor for reduced response.

What other medicines interact with Rimegepant?

MediHelp also lists interactions of Rimegepant with, for example, Amobarbital, Atazanavir, Butabarbital. The full list is on the Rimegepant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in